FDA Approved: CARAFATE — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Carafate (sucralfate) submitted by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer
• Stress Ulcers in Critically Ill Patients

Drugs mentioned

• CARAFATE (sucralfate)

Snippet

SUPPL AP for CARAFATE (SUCRALFATE)